BETAMETHASONE DIPROPIONATE
Generic: BETAMETHASONE DIPROPIONATE
Sun Pharmaceutical IndustriesManufacturer
TOPICALRoute
BETAMETHASONE DIPROPIONATEActive Substance
2007-05-21Original Approval
BETAMETHASONE DIPROPIONATE is FDA application ANDA077477, sponsored by SUN PHARMA CANADA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Betamethasone Dipropionate Cream USP, 0.05%, 45 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0055-46cGMP deviations: Temperature abuse
Class III2019-08-07
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark PharmTemperature Abuse: Complaints received of liquidy texture.
Class III2022-02-25
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro PharmaceuticaFailed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropio
Top Reported Reactions
1
DRUG INEFFECTIVE
1,461 reports
2
OFF LABEL USE
628 reports
3
PSORIASIS
570 reports
4
MACULAR DEGENERATION
532 reports
5
NAUSEA
532 reports
6
PAIN
489 reports
7
PRURITUS
488 reports
8
FATIGUE
441 reports
9
PAIN IN EXTREMITY
412 reports
10
RASH
408 reports